Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
about
Biomarkers in development of psychotropic drugs.Experimental panic provocation in healthy man-a translational role in anti-panic drug development?Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.Translational research in central nervous system drug discovery.Temporal association of elevated cholecystokininergic tone and adolescent trauma is critical for posttraumatic stress disorder-like behavior in adult mice.Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjectsBiological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic.
P2860
Q33993209-EFBA7FAE-EE87-40EE-8C87-CB20AC4EE9EDQ35686873-428CFC90-C1F7-4EF1-A1AD-67F76CE87CEBQ36156471-AB687A82-C65E-4CD2-A210-32B360283D68Q36401418-015E198E-C061-44D3-8276-22DA70267F17Q36782164-FB565DB4-1659-4DA9-B3A0-4D3EE77592E5Q36860047-1ACA4A8B-516B-47A0-9A9E-E6EFE97D4204Q37030195-A851AFC8-D1E7-4231-ACD6-BB906CA54B0DQ37686937-D4AA4F7A-D4BC-463E-9F9D-17AB9A484F2BQ46061246-039FD4BE-51E7-4916-865E-E0EF9DD4F069Q46533458-E2EA776C-7F8A-43B5-9EA9-4D7894771A64Q48187400-1F9146C7-65B6-4EC7-BE2B-B11974F8A1AEQ50582409-F7024D6F-0EF4-4FB2-98C9-B9A651050073
P2860
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@en
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@nl
type
label
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@en
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@nl
prefLabel
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@en
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@nl
P2093
P2860
P921
P356
P1476
Effects of alprazolam on chole ...... y: a placebo-controlled study.
@en
P2093
H-J Möller
P Zwanzger
R Rupprecht
T C Baghai
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300131
P407
P577
2003-03-26T00:00:00Z